These ClinROs (PASI, PGA) and PROs (DLQI) are not routinely captured in clinical care so completion rates vary. OM1’s relationships with our Dermatology Network can be leveraged to solicit these directly through OM1’s protocol-driven ClinPRO program.
We have provided a code set below to help you identify those patients with a lab in the JIA or PsA datasets. The anti-CCP positive/negative status is available via the following three LOINC codes: LOINC Code LOINC Name 53028-7 Cyclic citrullinated peptide Ab [Presence] in Serum 63375-0 Cyclic citrullinated peptide IgA+IgG Ab [Presence] in Serum[…]
We would expect to find one or more annual lab panels for patients treated with a biologic therapy or cDMARD. Expected labs may include: CBC, CMP, Hep B Panel, Hep C Ab, and Quantiferon Gold (TB).
It is not expected that we would have a high fill rate for vitals at dermatology visits. These are not routinely captured in clinical practice.
Severities are pulled directly from the clinical notes or, as available, from structured fields.
